Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 1.32% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Poor long term growth as Operating profit has grown by an annual rate 1.32% of over the last 5 years
3
Flat results in Mar 24
4
Risky -
5
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Services to the Health Industry
EUR 1,218 Million (Small Cap)
16.00
NA
0.00%
0.95
5.52%
1.88
Revenue and Profits:
Net Sales:
290 Million
(Quarterly Results - Jun 2025)
Net Profit:
5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-59.92%
0%
-59.92%
6 Months
-59.92%
0%
-59.92%
1 Year
-71.0%
0%
-71.0%
2 Years
-60.38%
0%
-60.38%
3 Years
-60.25%
0%
-60.25%
4 Years
-46.68%
0%
-46.68%
5 Years
-21.05%
0%
-21.05%
CompuGroup Medical SE & Co. KGaA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.22%
EBIT Growth (5y)
1.32%
EBIT to Interest (avg)
10.30
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
0.90
Sales to Capital Employed (avg)
0.80
Tax Ratio
43.28%
Dividend Payout Ratio
7.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.20%
ROE (avg)
15.54%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.16
EV to EBIT
13.92
EV to EBITDA
7.88
EV to Capital Employed
1.61
EV to Sales
1.78
PEG Ratio
0.74
Dividend Yield
3.61%
ROCE (Latest)
11.58%
ROE (Latest)
13.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 64 Schemes (6.69%)
Foreign Institutions
Held by 251 Foreign Institutions (20.26%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
289.60
277.20
4.47%
Operating Profit (PBDIT) excl Other Income
45.40
55.20
-17.75%
Interest
7.30
7.90
-7.59%
Exceptional Items
-1.80
1.20
-250.00%
Consolidate Net Profit
5.30
13.80
-61.59%
Operating Profit Margin (Excl OI)
64.10%
96.40%
-3.23%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 4.47% vs -8.88% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -61.59% vs -55.63% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,213.00
1,154.00
5.11%
Operating Profit (PBDIT) excl Other Income
198.20
201.30
-1.54%
Interest
34.20
36.30
-5.79%
Exceptional Items
-10.60
-2.80
-278.57%
Consolidate Net Profit
28.70
34.80
-17.53%
Operating Profit Margin (Excl OI)
75.50%
77.70%
-0.22%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 5.11% vs -2.84% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -17.53% vs -25.80% in Dec 2024
About CompuGroup Medical SE & Co. KGaA 
CompuGroup Medical SE & Co. KGaA
Services to the Health Industry
No Details Available.
Company Coordinates 
No Company Details Available






